Lakisha Knight
Psychiatric/Mental Health · Bessemer, ALNPI 1588183297
Payments from drug & device makers
Across 21 payments — averaging $18.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$120
- Bausch Health US, LLC$62
- AbbVie$47
- Takeda Pharmaceuticals U.S.A., Inc.$36
- Alkermes, Inc.$36
- Vanda Pharmaceuticals Inc.$33
- plus $61 from 3 others
What the payments were for
- Food & beverage$395100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $120 |
| Bausch Health US, LLC | 4 | $62 |
| AbbVie | 3 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Alkermes, Inc. | 2 | $36 |
| Vanda Pharmaceuticals Inc. | 1 | $33 |
| Lundbeck LLC | 1 | $21 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $20 |
| Johnson & Johnson | 1 | $19 |
How this compares
$395 in reported general payments places this provider in the 35th percentile of 378 psychiatric/mental health providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Olanzapine | 42 | $565 |
| Divalproex Sodium | 30 | $361 |
| Divalproex Sodium ErDivalproex Sodium | 14 | $344 |
| Quetiapine Fumarate | 44 | $217 |
| Fluvoxamine Maleate | 17 | $191 |
| Benztropine Mesylate | 12 | $184 |
| Risperidone | 15 | $140 |
| Buspirone Hcl | 21 | $132 |
| Citalopram HbrCitalopram Hydrobromide | 23 | $118 |
| Trazodone Hcl | 37 | $116 |
| Escitalopram Oxalate | 14 | $116 |
| Clonazepam | 30 | $84 |
| Clonidine Hcl | 25 | $65 |
| Duloxetine Hcl | 12 | $27 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Bessemer
- Laura GrahamMontgomery$80K
- Yuliya SpencerBirmingham$65K
- Keri BarrBay Minette$35K
- John HayesMobile$30K
- Logan ThrasherHoover$22K
- Anthony PhillipsHelena$15K
- Ian KinzerHuntsville$15K
- Latisha AliHoover$15K
- Taylor BarrettGadsden$15K
- Angela GarrardGadsden$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.